FDA advisors counsel complete approval of Pfizer’s Covid drug Paxlovid
The FDA’s Unbiased Advisors Committee has beneficial complete approval of Pfizer’s antiviral remedy Paxlovid for adults at excessive menace of critical illness from Covid. The Meals and Drug Management (FDA) first made Paxlovid to be had in December 2021 for emergency use in high-risk folks ages 12 and older. Pfizer submitted an software for complete … Read more